MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 584617 | Name: Bexlosteride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Bexlosteride is used in the treatment of prostate cancer and inhibits Human Type I Isoform of 5alpha-Reductase.

Chemical Structure

Bexlosteride
Bexlosteride
CAS#148905-78-6

Theoretical Analysis

MedKoo Cat#: 584617

Name: Bexlosteride

CAS#: 148905-78-6

Chemical Formula: C14H16ClNO

Exact Mass: 249.0920

Molecular Weight: 249.74

Elemental Analysis: C, 67.33; H, 6.46; Cl, 14.19; N, 5.61; O, 6.41

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Bexlosteride; LY300502
IUPAC/Chemical Name
(4aR,10bR)-8-Chloro-1,4,4a,5,6,10b-hexahydro-4-methylbenzo(f)quinolin-3(2H)-one
InChi Key
WQBIOEFDDDEARX-CHWSQXEVSA-N
InChi Code
InChI=1S/C14H16ClNO/c1-16-13-6-2-9-8-10(15)3-4-11(9)12(13)5-7-14(16)17/h3-4,8,12-13H,2,5-7H2,1H3/t12-,13-/m1/s1
SMILES Code
O=C1N(C)[C@]2([H])CCC3=CC(Cl)=CC=C3[C@@]2([H])CC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 249.74 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sutkowski DM, Audia JE, Goode RL, Hsiao KC, Leibovitch IY, McNulty AM, Neubauer BL. Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5alpha-reductase inhibitor. Prostate Suppl. 1996;6:62-6. PubMed PMID: 8630232. 2: Ekins S, Bravi G, Binkley S, Gillespie JS, Ring BJ, Wikel JH, Wrighton SA. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors. Drug Metab Dispos. 2000 Aug;28(8):994-1002. PubMed PMID: 10901712.

View History

Thalidomide 5'-amine-alkylC8-amine

Thalidomide 5'-amine-alkylC8-amine

Featured